Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Spa17 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Spa17 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of SPA17 mRNA | CTD | PMID:17555576 | Spa17 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Spa17 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SPA17 mRNA | CTD | PMID:17942748 | Spa17 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Spa17 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of SPA17 mRNA | CTD | PMID:17942748 | Spa17 | Rat | 17beta-estradiol | decreases expression | ISO | Spa17 (Mus musculus) | 6480464 | Estradiol results in decreased expression of SPA17 mRNA | CTD | PMID:39298647 | Spa17 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of SPA17 mRNA | CTD | PMID:16631469 | Spa17 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Spa17 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SPA17 mRNA | CTD | PMID:17942748 | Spa17 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of SPA17 mRNA] | CTD | PMID:21215274 | Spa17 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SPA17 mRNA | CTD | PMID:21215274 | Spa17 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Spa17 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SPA17 mRNA | CTD | PMID:17942748 | Spa17 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | EXP | | 6480464 | 2,3,7,8-tetrachlorodibenzofuran results in increased expression of SPA17 mRNA | CTD | PMID:32109520 | Spa17 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of SPA17 mRNA | CTD | PMID:21346803 | Spa17 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of SPA17 mRNA | CTD | PMID:21346803 | Spa17 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | SPA17 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of SPA17 mRNA | CTD | PMID:25912373 | Spa17 | Rat | 4-hydroxynon-2-enal | increases expression | ISO | Spa17 (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in increased expression of SPA17 mRNA | CTD | PMID:19191707 | Spa17 | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Spa17 (Mus musculus) | 6480464 | Fenretinide results in increased expression of SPA17 mRNA | CTD | PMID:28973697 | Spa17 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of SPA17 mRNA | CTD | PMID:25825206 | Spa17 | Rat | aflatoxin B1 | affects expression | ISO | SPA17 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of SPA17 protein | CTD | PMID:20106945 | Spa17 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of SPA17 mRNA | CTD | PMID:33354967 | Spa17 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SPA17 mRNA | CTD | PMID:16483693 | Spa17 | Rat | antirheumatic drug | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of SPA17 mRNA | CTD | PMID:24449571 | Spa17 | Rat | Aroclor 1254 | increases expression | ISO | Spa17 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of SPA17 mRNA | CTD | PMID:23650126 | Spa17 | Rat | arsane | multiple interactions | ISO | SPA17 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPA17 more ... | CTD | PMID:39836092 | Spa17 | Rat | arsenic atom | multiple interactions | ISO | SPA17 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPA17 more ... | CTD | PMID:39836092 | Spa17 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Spa17 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of SPA17 mRNA | CTD | PMID:33754040 | Spa17 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SPA17 mRNA | CTD | PMID:25181051|PMID:30816183|PMID:32528016 | Spa17 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of SPA17 gene | CTD | PMID:28505145 | Spa17 | Rat | bisphenol A | increases expression | ISO | Spa17 (Mus musculus) | 6480464 | bisphenol A results in increased expression of SPA17 mRNA | CTD | PMID:27623287 | Spa17 | Rat | bisphenol F | decreases expression | ISO | Spa17 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of SPA17 mRNA | CTD | PMID:38685157 | Spa17 | Rat | carbon nanotube | decreases expression | ISO | Spa17 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of SPA17 mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681 | Spa17 | Rat | CGP 52608 | multiple interactions | ISO | SPA17 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SPA17 gene] | CTD | PMID:28238834 | Spa17 | Rat | chloroprene | increases expression | ISO | Spa17 (Mus musculus) | 6480464 | Chloroprene results in increased expression of SPA17 mRNA | CTD | PMID:23125180 | Spa17 | Rat | cobalt dichloride | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of SPA17 mRNA | CTD | PMID:19376846 | Spa17 | Rat | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of SPA17 mRNA | CTD | PMID:24386269 | Spa17 | Rat | copper(II) sulfate | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of SPA17 mRNA | CTD | PMID:19549813 | Spa17 | Rat | corosolic acid | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | corosolic acid results in decreased expression of SPA17 mRNA | CTD | PMID:37939859 | Spa17 | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of SPA17 mRNA | CTD | PMID:26577399 | Spa17 | Rat | cyclosporin A | affects expression | ISO | SPA17 (Homo sapiens) | 6480464 | Cyclosporine affects the expression of SPA17 mRNA | CTD | PMID:20106945 | Spa17 | Rat | cyclosporin A | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SPA17 mRNA | CTD | PMID:25562108 | Spa17 | Rat | dioxygen | multiple interactions | ISO | Spa17 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SPA17 mRNA | CTD | PMID:30529165 | Spa17 | Rat | dorsomorphin | multiple interactions | ISO | SPA17 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Spa17 | Rat | doxorubicin | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SPA17 mRNA | CTD | PMID:29803840 | Spa17 | Rat | furan | decreases methylation | EXP | | 6480464 | furan results in decreased methylation of SPA17 gene | CTD | PMID:22079235 | Spa17 | Rat | genistein | decreases expression | ISO | Spa17 (Mus musculus) | 6480464 | Genistein results in decreased expression of SPA17 mRNA | CTD | PMID:32186404 | Spa17 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SPA17 mRNA | CTD | PMID:33387578 | Spa17 | Rat | hydrogen peroxide | affects expression | ISO | SPA17 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of SPA17 mRNA | CTD | PMID:20044591 | Spa17 | Rat | isobutanol | multiple interactions | ISO | SPA17 (Homo sapiens) | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic more ... | CTD | PMID:29432896 | Spa17 | Rat | ivermectin | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of SPA17 protein | CTD | PMID:32959892 | Spa17 | Rat | lead diacetate | affects expression | EXP | | 6480464 | lead acetate affects the expression of SPA17 mRNA | CTD | PMID:21864555 | Spa17 | Rat | leflunomide | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of SPA17 mRNA | CTD | PMID:28988120 | Spa17 | Rat | levofloxacin | decreases expression | EXP | | 6480464 | Levofloxacin results in decreased expression of SPA17 mRNA | CTD | PMID:24136188 | Spa17 | Rat | manganese atom | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Manganese results in decreased expression of SPA17 mRNA | CTD | PMID:17175027 | Spa17 | Rat | manganese(0) | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Manganese results in decreased expression of SPA17 mRNA | CTD | PMID:17175027 | Spa17 | Rat | manganese(II) chloride | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | manganese chloride results in decreased expression of SPA17 mRNA | CTD | PMID:17175027 | Spa17 | Rat | methylmercury chloride | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of SPA17 mRNA | CTD | PMID:28001369 | Spa17 | Rat | Moniliformin | decreases expression | ISO | Spa17 (Mus musculus) | 6480464 | moniliformin results in decreased expression of SPA17 mRNA | CTD | PMID:39984025 | Spa17 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SPA17 mRNA | CTD | PMID:20360939 | Spa17 | Rat | nitrates | multiple interactions | ISO | Spa17 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SPA17 more ... | CTD | PMID:35964746 | Spa17 | Rat | ozone | multiple interactions | ISO | Spa17 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased more ... | CTD | PMID:34911549 | Spa17 | Rat | p-toluidine | increases expression | EXP | | 6480464 | 4-toluidine results in increased expression of SPA17 mRNA | CTD | PMID:27638505 | Spa17 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SPA17 mRNA | CTD | PMID:33387578 | Spa17 | Rat | perfluorooctanoic acid | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of SPA17 mRNA | CTD | PMID:36326898 | Spa17 | Rat | phenethyl caffeate | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SPA17 mRNA | CTD | PMID:20360939 | Spa17 | Rat | phenobarbital | affects expression | ISO | SPA17 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of SPA17 mRNA | CTD | PMID:19159669 | Spa17 | Rat | phenylmercury acetate | multiple interactions | ISO | SPA17 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Spa17 | Rat | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of SPA17 mRNA | CTD | PMID:19162173 | Spa17 | Rat | quercetin | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of SPA17 mRNA | CTD | PMID:21632981 | Spa17 | Rat | quinolin-8-ol | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Oxyquinoline results in decreased expression of SPA17 mRNA | CTD | PMID:21632981 | Spa17 | Rat | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of SPA17 mRNA | CTD | PMID:28374803 | Spa17 | Rat | SB 431542 | multiple interactions | ISO | SPA17 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Spa17 | Rat | sodium arsenite | increases expression | ISO | SPA17 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of SPA17 mRNA | CTD | PMID:28595984|PMID:34032870 | Spa17 | Rat | sodium arsenite | multiple interactions | ISO | SPA17 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of SPA17 more ... | CTD | PMID:39836092 | Spa17 | Rat | sodium fluoride | decreases expression | ISO | Spa17 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of SPA17 mRNA | CTD | PMID:21340527 | Spa17 | Rat | sodium fluoride | increases expression | ISO | Spa17 (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of SPA17 protein | CTD | PMID:28918527 | Spa17 | Rat | sunitinib | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of SPA17 mRNA | CTD | PMID:31533062 | Spa17 | Rat | tamoxifen | affects expression | ISO | Spa17 (Mus musculus) | 6480464 | Tamoxifen affects the expression of SPA17 mRNA | CTD | PMID:17555576 | Spa17 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of SPA17 mRNA | CTD | PMID:33387578 | Spa17 | Rat | thalidomide | decreases expression | ISO | Spa17 (Mus musculus) | 6480464 | Thalidomide results in decreased expression of SPA17 mRNA | CTD | PMID:26217789 | Spa17 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SPA17 mRNA | CTD | PMID:34492290 | Spa17 | Rat | thiram | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Thiram results in decreased expression of SPA17 mRNA | CTD | PMID:38568856 | Spa17 | Rat | titanium dioxide | decreases expression | ISO | Spa17 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of SPA17 mRNA | CTD | PMID:23557971 | Spa17 | Rat | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of SPA17 gene | CTD | PMID:27618143 | Spa17 | Rat | trichostatin A | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of SPA17 mRNA | CTD | PMID:26272509 | Spa17 | Rat | trichostatin A | multiple interactions | ISO | SPA17 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Spa17 | Rat | triptonide | increases expression | ISO | Spa17 (Mus musculus) | 6480464 | triptonide results in increased expression of SPA17 mRNA | CTD | PMID:33045310 | Spa17 | Rat | urethane | decreases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Urethane results in decreased expression of SPA17 mRNA | CTD | PMID:28818685 | Spa17 | Rat | valproic acid | increases expression | ISO | Spa17 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of SPA17 mRNA | CTD | PMID:21427059 | Spa17 | Rat | valproic acid | decreases methylation | ISO | SPA17 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of SPA17 gene | CTD | PMID:29154799 | Spa17 | Rat | valproic acid | increases expression | ISO | SPA17 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SPA17 mRNA | CTD | PMID:19101580|PMID:23179753|PMID:28001369|PMID:29154799 | Spa17 | Rat | valproic acid | affects expression | ISO | SPA17 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SPA17 mRNA | CTD | PMID:25979313 | Spa17 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of SPA17 mRNA | CTD | PMID:22570695 | Spa17 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of SPA17 mRNA | CTD | PMID:19015723 | Spa17 | Rat | vorinostat | increases expression | ISO | SPA17 (Homo sapiens) | 6480464 | vorinostat results in increased expression of SPA17 mRNA | CTD | PMID:27188386 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















